Securities code: 003042 securities abbreviation: Shandongsino-Agriunitedbiotechnologyco.Ltd(003042) Announcement No.: 2022-002 Shandongsino-Agriunitedbiotechnologyco.Ltd(003042)
Stock trading abnormal fluctuation announcement
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete,
There are no false records, misleading statements or material omissions. 1、 Introduction to abnormal fluctuations in stock trading
Shandongsino-Agriunitedbiotechnologyco.Ltd(003042) (hereinafter referred to as “the company” or “the company”), securities abbreviation: Shandongsino-Agriunitedbiotechnologyco.Ltd(003042) , securities code: 003042) the cumulative deviation of the closing price increase of the stock for two consecutive trading days on January 18, 2022 and January 19, 2022 exceeds 20%. According to the relevant regulations of Shenzhen Stock Exchange, it belongs to the abnormal fluctuation of stock trading. 2、 Description of the company’s concern and verification
In view of the abnormal fluctuation of the company’s stock trading, the company has verified the relevant matters and the controlling shareholders and actual controllers. The relevant information is described as follows:
1. There is no need to supplement or correct the information disclosed by the company in the early stage.
2. The company has not found any unpublished material information reported by public media that may or has had a great impact on the stock trading price of the company.
3. Recently, the company’s production and operation are normal, and the internal and external business environment has not changed significantly.
4. After verification, the company, its controlling shareholders and actual controllers do not have any major events that should be disclosed but not disclosed, nor do they have any major events in the planning stage.
5. After verification, the controlling shareholder and actual controller of the company did not buy or sell the company’s shares during the abnormal fluctuation of the company’s stock trading. 3、 Whether there is a description of the information that should be disclosed but not disclosed
The board of directors of the company confirms that the company has no undisclosed matters or planning, negotiation, intention, agreement, etc. related to the matters that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange (hereinafter referred to as the “Stock Listing Rules”); The board of directors has not been informed that the company has undisclosed information that should be disclosed in accordance with the stock listing rules and other relevant provisions and has a great impact on the trading price of the company’s shares and their derivatives; There is no need to correct or supplement the information disclosed by the company in the early stage. 4、 Risk tips deemed necessary by listed companies
1. Through self inspection, the company does not violate fair information disclosure.
2. The company has disclosed the announcement on abnormal fluctuation of stock trading (Announcement No.: 2022-001) on January 17, 2022, because the cumulative deviation of the increase of the company’s stock price for two consecutive trading days on January 13, 2022 and January 14, 2022 exceeds 20%.
3. The company solemnly reminds investors: securities times, Securities Daily, China Securities News, Shanghai Securities News and cninfo（ http://www.cn.info.com.cn. ）As the information disclosure media designated by the company, all information of the company shall be subject to the information published in the above designated media. The company will conscientiously perform the obligation of information disclosure and do a good job of information disclosure in a timely manner in strict accordance with the provisions and requirements of relevant laws and regulations. Please invest rationally and pay attention to risks.
It is hereby announced.
Shandongsino-Agriunitedbiotechnologyco.Ltd(003042) board of directors
January 20, 2022
